Literature DB >> 16778415

Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss.

Menachem Gross1, Gideon Friedman, Ron Eliashar, Nira Koren-Morag, Neta Goldschmidt, Iman Abou Atta, Arie Ben-Yehuda.   

Abstract

Idiopathic sudden sensorineural hearing loss (SSNHL) represents a frequently encountered otological disease of unknown etiology. In recent years, several inherited risk factors have been found in the pathogenesis of vascular diseases. In the present study, we determined whether specific polymorphism or the combination of polymorphisms in folate-dependent homocysteine metabolism genes can act as predisposing inherited vascular risk factors in the development of SSNHL. We conducted a prospective case-control study using DNA samples extracted from 81 patients diagnosed as suffering from SSNHL and 264 healthy control subjects. Three functional polymorphisms were analyzed by polymerase chain reaction amplification, restriction enzyme digestion, and DNA fragment separation by electrophoresis: methylenetetrahydrofolate reductase (MTHFR) C677T, MTHFR A1298C, and methionine synthase (MTR) A2756G polymorphisms. The prevalence of the homozygous genotype of MTR 2756GG in the SSNHL patients (9%) was significantly higher than in the control group (4%) (p = 0.011). The allelic frequency of the G allele of the MTR A2756G polymorphism among SSNHL patients (12.5%) was also significantly higher than in the control group (5%) (p = 0.033). The prevalence of patients possessing two polymorphisms (31%) and three polymorphisms (17%) in the SSNHL group was significantly higher than in the control group (23 and 9%, respectively; p = 0.019). The frequency of patients with a very high rank risk (double homozygous) was significantly higher in the SSNHL group, MTHFR 677TT/MTR 2675GG--7%, than the frequency of patients in the control group, MTHFR 677TT/MTR 2675GG--3% (p = 0.030). Certain polymorphisms in genes encoding enzymes in the folate-dependent homocysteine metabolism are associated with SSNHL. In our case-control study, a significant association between MTR 2756GG genotype and SSNHL was found which may represent an inherited vascular risk factor in the pathogenesis of SSNHL. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16778415     DOI: 10.1159/000093957

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  5 in total

Review 1.  Association between the V Leiden G1691A mutation and sudden sensorineural hearing loss in Italian population: a meta-analysis.

Authors:  Jingcheng Shu; Yongfeng Si; Shihua Yin; Meirong He
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-30       Impact factor: 2.503

2.  MTHFR 677T is a strong determinant of the degree of hearing loss among Polish males with postlingual sensorineural hearing impairment.

Authors:  Agnieszka Pollak; Malgorzata Mueller-Malesinska; Urszula Lechowicz; Agata Skorka; Lech Korniszewski; Agnieszka Sobczyk-Kopciol; Anna Waskiewicz; Grazyna Broda; Katarzyna Iwanicka-Pronicka; Monika Oldak; Henryk Skarzynski; Rafał Płoski
Journal:  DNA Cell Biol       Date:  2012-03-16       Impact factor: 3.311

Review 3.  Association between the methylenetetrahydrofolate reductase gene C677T polymorphism and sudden sensorineural hearing loss: a meta-analysis.

Authors:  Jingcheng Shu; Shihua Yin; An-Zhou Tan; Meirong He
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-11       Impact factor: 2.503

4.  Hearing impairment risk and interaction of folate metabolism related gene polymorphisms in an aging study.

Authors:  Yasue Uchida; Saiko Sugiura; Fujiko Ando; Tsutomu Nakashima; Hiroshi Shimokata
Journal:  BMC Med Genet       Date:  2011-03-07       Impact factor: 2.103

5.  Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study.

Authors:  A Joan Levine; Won Lee; Jane C Figueiredo; David V Conti; David J Vandenberg; Brian D Davis; Christopher K Edlund; Susanne M Henning; David Heber; Mariana C Stern; Robert W Haile
Journal:  Cancer Causes Control       Date:  2011-01-28       Impact factor: 2.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.